The event drew widespread attention, with enthusiastic participation from employees and people from all walks of life who follow the company’s development. Hundreds of heartfelt messages poured in, brimming with praise for Qidu Pharma’s achievements and blessings for the future.
Netizen “Zhao Xuekun” wrote: “Since its launch in 2001, the ‘Top Ten Events’ selection has become an annual milestone that chronicles the company’s development. From the old factory to a new journey, from ‘following’ to ‘leading’, every footnote of progress is a resounding step forward for the enterprise and a shared glory for all of us at Qidu Pharma.”
Netizen “Free as the Wind” wrote: “Chasing dreams across mountains and seas, we don’t feel the distance; though the road ahead stretches long, we stride ahead boldly. Let us summon the courage of a galloping steed, unleash the vitality of charging horses, and keep motivated like a horse rushing forward. Together, let’s fight for our dreams and work hard for our happiness, turning a grand vision into a beautiful reality. When each of our ‘small families’ is brimming with warmth and energy, the big family of Qidu Pharma will thrive and grow more prosperous with every passing day.”
Recommended reading
-
January 20, 2025Top Ten Events of Qidu Pharmaceutical Group in 2025 Announced
-
June 17, 2026Qidu Pharma’s intelligent production project for oral preparations with an annual capacity of 10 billion tablets/granules passed the GMP on-site inspection.
-
September 19, 2026Ujoin Medical Technology’s COP/COC Prefilled Syringe Production and Assembly Line Officially Put into Operation
-
September 19, 2026Qidu Pharmaceutical 2026: Summer Daycare and Scholarship/Bursary Programs – Care Underway
-
September 07, 2026Qidu Pharmaceutical’s Ruihuanjia® – Hemofiltration Replacement Fluid of Sodium Citrate Receives NMPA Approval for Marketing
-
September 07, 2026Qidu Pharmaceutical’s Fat Emulsion Injection (C14-24) Passes Generic Drug Consistency Evaluation
-
September 07, 2026Qidu Pharmaceutical’s Yiruiqing® - Rosuvastatin Calcium and Ezetimibe Tablets (I) Approved for Marketing